Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells

International Immunology

Volumn 25, Issue 4, 2013, Pages 221-233

  Garcia Vallejo, Juan J ^a   Koning, Nathalie ^a   Ambrosini, Martino ^a   Kalay, Hakan ^a   Vuist, Ilona ^a   Sarrami Forooshani, Ramin ^b   Geijtenbeek, Teunis B H ^b   van Kooyk, Yvette ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Competitive inhibition; Gp120; Human; Infectious disease; Lewisx

Indexed keywords

CD209 ANTIGEN; DENDRIMER; GLYCODENDRIMER; GLYCOPROTEIN GP 120; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CELL MATURATION; DENDRITIC CELL; GEOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS TRANSMISSION;

BINDING, COMPETITIVE; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRIMERS; DENDRITIC CELLS; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE EVASION; LECTINS, C-TYPE; LEWIS BLOOD-GROUP SYSTEM; MOLECULAR TARGETED THERAPY; POLYSACCHARIDES; RECEPTORS, CELL SURFACE; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS INTERNALIZATION;

EID: 84875244076     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs115     Document Type: Article

References (58)

1. Mellman, I. and Steinman, R. M. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255.
2. Steinman, R. M. and Banchereau, J. 2007. Taking dendritic cells into medicine. Nature 449:419.
3. Blander, J. M. and Sander, L. E. 2012. Beyond pattern recognition: five immune checkpoints for scaling the microbial threat. Nat. Rev. Immunol. 12:215.
4. Drickamer, K. 1999. C-type lectin-like domains. Curr. Opin. Struct. Biol. 9:585.
5. Sancho, D. and Reis e Sousa, C. 2012. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu. Rev. Immunol. 30:491.
6. Geijtenbeek, T. B. and Gringhuis, S. I. 2009. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 9:465.
7. Wu, L. and KewalRamani, V. N. 2006. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev. Immunol. 6:859.
8. Geijtenbeek, T. B., Kwon, D. S., Torensma, R. et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587.
9. Turville, S. G., Cameron, P. U., Handley, A. et al. 2002. Diversity of receptors binding HIV on dendritic cell subsets. Nat. Immunol. 3:975.
10. McDonald, D., Wu, L., Bohks, S. M., KewalRamani, V. N., Unutmaz, D. and Hope, T. J. 2003. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300:1295.
11. de Witte, L., Nabatov, A., Pion, M. et al. 2007. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 13:367.
12. Holla, A. and Skerra, A. 2011. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin. Protein Eng. Des. Sel. 24:659.
13. de Witte, L., Nabatov, A. and Geijtenbeek, T. B. H. 2008. Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission. Trends Mol. Med. 14:12.
14. Dam, T. K. and Brewer, C. F. 2010. Lectins as pattern recognition molecules: the effects of epitope density in innate immunity. Glycobiology 20:270.
15. Doores, K. J., Bonomelli, C., Harvey, D. J. et al. 2010. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proc. Natl Acad. Sci. USA 107:13800.
16. Biricova, V. and Laznickova, A. 2009. Dendrimers: analytical characterization and applications. Bioorg. Chem. 37:185.
17. Sallusto, F., Cella, M., Danieli, C. and Lanzavecchia, A. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389.
18. Sallusto, F. and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by GM-CSF plus IL-4 and downregulated by TNF-a. J. Exp. Med. 179:1109.
19. Geijtenbeek, T. B., Torensma, R., van Vliet, S. J. et al. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100:575.
20. Engering, A., Geijtenbeek, T. B., van Vliet, S. J. et al. 2002. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168:2118.
21. Arrighi, J. F., Pion, M., Wiznerowicz, M. et al. 2004. Lentivirusmediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J. Virol. 78:10848.
22. de Jong, M. A., de Witte, L., Oudhoff, M. J., Gringhuis, S. I., Gallay, P. and Geijtenbeek, T. B. 2008. TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J. Clin. Invest. 118:3440.
23. Geijtenbeek, T., van Kooyk, Y., van Vliet, S. J., Renes, M. H., Raymakers, R. and Figdor, C. G. 1999. High frequency of adhesion defects in B-lineage acute lymphoblastic leukemia. Blood 94:754.
24. Fawcett, J., Holness, C. L., Needham, L. A. et al. 1992. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 360:481.
25. Ortyn, W. E., Hall, B. E., George, T. C. et al. 2006. Sensitivity measurement and compensation in spectral imaging. Cytometry A 69:852.
26. Ortyn, W. E., Perry, D. J., Venkatachalam, V. et al. 2007. Extended depth of field imaging for high speed cell analysis. Cytometry A 71:215.
27. Bovin, N. V. 1998. Polyacrylamide-based glycoconjugates as tools in glycobiology. Glycoconj. J. 15:431.
28. Mitchell, D. A., Fadden, A. J. and Drickamer, K. 2001. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J. Biol. Chem. 276:28939.
29. Tacken, P. J., Ter Huurne, M., Torensma, R. and Figdor, C. G. 2012. Antibodies and carbohydrate ligands binding to DC-SIGN differentially modulate receptor trafficking. Eur. J. Immunol. 42:1989.
30. Unger, W. W., van Beelen, A. J., Bruijns, S. C. et al. 2012. Glycanmodified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells. J. Control. Release 160:88.
31. Basiji, D. A., Ortyn, W. E., Liang, L., Venkatachalam, V. and Morrissey, P. 2007. Cellular image analysis and imaging by flow cytometry. Clin. Lab. Med. 27:653.
32. Tomalia, D. A. 1996. Starburstr' dendrimers-nanoscopic supermolecules according to dendritic rules and principles. Macromol. Symp. 101:243.
33. Esfand, R. and Tomalia, D. A. 2001. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov. Today 6:427.
34. Feinberg, H., Guo, Y., Mitchell, D. A., Drickamer, K. and Weis, W. I. 2005. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J. Biol. Chem. 280:1327.
35. Menon, S., Rosenberg, K., Graham, S. A. et al. 2009. Bindingsite geometry and flexibility in DC-SIGN demonstrated with surface force measurements. Proc. Natl Acad. Sci. USA 106:11524.
36. Tabarani, G., Thépaut, M., Stroebel, D. et al. 2009. DC-SIGN neck domain is a pH-sensor controlling oligomerization: SAXS and hydrodynamic studies of extracellular domain. J. Biol. Chem. 284:21229.
37. Anderluh, M., Jug, G., Svajger, U. and Obermajer, N. 2012. DC-SIGN antagonists, a potential new class of anti-infectives. Curr. Med. Chem. 19:992.
38. Mitchell, D. A., Jones, N. A., Hunter, S. J. et al. 2007. Synthesis of 2-C-branched derivatives of d-mannose: 2-C-aminomethyl-dmannose binds to the human C-type lectin DC-SIGN with affinity greater than an order of magnitude compared to that of d-mannose. Tetrahedron Asym. 18:1502.
39. Reina, J. J., Sattin, S., Invernizzi, D. et al. 2007. 1,2-Mannobioside mimic: synthesis, DC-SIGN interaction by NMR and docking, and antiviral activity. ChemMedChem. 2:1030.
40. Mari, S., Sánchez-Medina, I., Mereghetti, P., Belvisi, L., Jiménez- Barbero, J. and Bernardi, A. 2007. Synthesis and conformational analysis of an alpha-D-mannopyranosyl-(1->2)-alpha-D-mannopyranosyl-( 1->6)-alpha-D-mannopyranose mimic. Carbohydr. Res. 342:1859.
41. Garber, K. C., Wangkanont, K., Carlson, E. E. and Kiessling, L. L. 2010. A general glycomimetic strategy yields non-carbohydrate inhibitors of DC-SIGN. Chem. Commun. (Camb.). 46:6747.
42. Mangold, S. L., Prost, L. R. and Kiessling, L. L. 2012. Quinoxalinone inhibitors of the lectin DC-SIGN. Chem. Sci. 3:772.
43. Obermajer, N., Sattin, S., Colombo, C. et al. 2011. Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists. Mol. Divers. 15:347.
44. Andreini, M., Doknic, D., Sutkeviciute, I. et al. 2011. Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin. Org. Biomol. Chem. 9:5778.
45. Timpano, G., Tabarani, G., Anderluh, M. et al. 2008. Synthesis of novel DC-SIGN ligands with an alpha-fucosylamide anchor. Chembiochem. 9:1921.
46. Sattin, S., Daghetti, A., Thépaut, M. et al. 2010. Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation. ACS Chem. Biol. 5:301.
47. Luczkowiak, J., Sattin, S., Sutkeviciute, I. et al. 2011. Pseudosaccharide functionalized dendrimers as potent inhibitors of DC-SIGN dependent Ebola pseudotyped viral infection. Bioconjug. Chem. 22:1354.
48. Berzi, A., Reina, J. J., Ottria, R. et al. 2012. A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models. AIDS 26:127.
49. Tabarani, G., Reina, J. J., Ebel, C. et al. 2006. Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding. FEBS Lett. 580:2402.
50. Wang, S. K., Liang, P. H., Astronomo, R. D. et al. 2008. Targeting the carbohydrates on HIV-1: interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN. Proc. Natl Acad. Sci. USA 105:3690.
51. Becer, C. R., Gibson, M. I., Geng, J. et al. 2010. High-affinity glycopolymer binding to human DC-SIGN and disruption of DC-SIGN interactions with HIV envelope glycoprotein. J. Am. Chem. Soc. 132:15130.
52. Martínez-Avila, O., Bedoya, L. M., Marradi, M., Clavel, C., Alcamí, J. and Penadés, S. 2009. Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells. Chembiochem. 10:1806.
53. Lasala, F., Arce, E., Otero, J. R., Rojo, J. and Delgado, R. 2003. Mannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in trans. Antimicrob. Agents Chemother. 47:3970.
54. Stern, S. T., Adiseshaiah, P. P. and Crist, R. M. 2012. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part. Fibre Toxicol. 9:20.
55. UNAIDS. 2010. United Nations Programme on HIV/AIDS. Report on the Global AIDS epidemic. Available at: http://www.unaids.org/en/dataanalysis/knowyourepidemic/epidemiologypublications/
56. Demberg, T. and Robert-Guroff, M. 2012. Controlling the HIV/AIDS epidemic: current status and global challenges. Front. Immunol. 3:250.
57. Galustian, C., Park, C. G., Chai, W. et al. 2004. High and low affinity carbohydrate ligands revealed for murine SIGN-R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN-R3 and langerin. Int. Immunol. 16:853.
58. Maingi, V., Jain, V., Bharatam, P. V. and Maiti, P. K. 2012. Dendrimer building toolkit: model building and characterization of various dendrimer architectures. J. Comput. Chem. 33:1997.